A pair of drugs that use the immune system to attack cancer cells shrunk tumours in nearly 60 per cent of people with advanced melanoma according to a recent study in the U.K. — though questions about survival, side-effects and cost remain.
from CBC | Health News http://ift.tt/1FZ4nRK
Aucun commentaire:
Enregistrer un commentaire